Donor Neutrophil Subsets to Predict the Risk of aGVHD

Active, not recruitingOBSERVATIONAL

Enrollment

260

Participants

Timeline

Start Date

December 1, 2023

Primary Completion Date

February 29, 2024

Study Completion Date

June 10, 2024

Conditions

Acute Graft-versus-Host Disease

Trial Locations (1)

Nanfang Hospital, Southern Medical University, Guangzhou

All Listed Sponsors

lead

Nanfang Hospital, Southern Medical University

OTHER

NCT06394895 - Donor Neutrophil Subsets to Predict the Risk of aGVHD | Biotech Hunter | Biotech Hunter